Chimeric antigen receptor (CAR) T-cell therapy has revolutionized the treatment of hematologic malignancies, achieving durable remission in patients who are refractory to conventional therapies. However, the limited persistence of infused CAR-T cells, due to T... ...

请注册登录后继续浏览